author_facet Dalyot-Herman, Nava
Bathe, Oliver F.
Malek, Thomas R.
Dalyot-Herman, Nava
Bathe, Oliver F.
Malek, Thomas R.
author Dalyot-Herman, Nava
Bathe, Oliver F.
Malek, Thomas R.
spellingShingle Dalyot-Herman, Nava
Bathe, Oliver F.
Malek, Thomas R.
The Journal of Immunology
Reversal of CD8+ T Cell Ignorance and Induction of Anti-Tumor Immunity by Peptide-Pulsed APC
Immunology
Immunology and Allergy
author_sort dalyot-herman, nava
spelling Dalyot-Herman, Nava Bathe, Oliver F. Malek, Thomas R. 0022-1767 1550-6606 The American Association of Immunologists Immunology Immunology and Allergy http://dx.doi.org/10.4049/jimmunol.165.12.6731 <jats:title>Abstract</jats:title><jats:p>In the present report, we have studied the potential of naive and activated effector CD8+ T cells to function as anti-tumor T cells to a solid tumor using OVA-specific T cells from TCR-transgenic OT-I mice. Adoptive transfer of naive OT-I T cells into tumor-bearing syngeneic mice did not inhibit tumor cell growth. The adoptively transferred OT-I T cells did not proliferate in lymphoid tissue of tumor-bearing mice and were not anergized by the tumor. In contrast, adoptive transfer of preactivated OT-I CTL inhibited tumor growth in a dose-dependent manner, indicating that E.G7 was susceptible to immune effector cells. Importantly, naive OT-I T cells proliferated and elicited an anti-tumor response if they were adoptively transferred into normal or CD4-deficient mice that were then vaccinated with GM-CSF-induced bone marrow-derived OVA-pulsed APC. Collectively, these data indicate that even though naive tumor-specific T cells are present at a relatively high fraction they remain ignorant of the tumor and demonstrate that a CD8-mediated anti-tumor response can be induced by Ag-pulsed APC without CD4 T cell help.</jats:p> Reversal of CD8+ T Cell Ignorance and Induction of Anti-Tumor Immunity by Peptide-Pulsed APC The Journal of Immunology
doi_str_mv 10.4049/jimmunol.165.12.6731
facet_avail Online
Free
finc_class_facet Medizin
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuNDA0OS9qaW1tdW5vbC4xNjUuMTIuNjczMQ
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuNDA0OS9qaW1tdW5vbC4xNjUuMTIuNjczMQ
institution DE-Zi4
DE-Gla1
DE-15
DE-Pl11
DE-Rs1
DE-14
DE-105
DE-Ch1
DE-L229
DE-D275
DE-Bn3
DE-Brt1
DE-Zwi2
DE-D161
imprint The American Association of Immunologists, 2000
imprint_str_mv The American Association of Immunologists, 2000
issn 1550-6606
0022-1767
issn_str_mv 1550-6606
0022-1767
language English
mega_collection The American Association of Immunologists (CrossRef)
match_str dalyotherman2000reversalofcd8tcellignoranceandinductionofantitumorimmunitybypeptidepulsedapc
publishDateSort 2000
publisher The American Association of Immunologists
recordtype ai
record_format ai
series The Journal of Immunology
source_id 49
title Reversal of CD8+ T Cell Ignorance and Induction of Anti-Tumor Immunity by Peptide-Pulsed APC
title_unstemmed Reversal of CD8+ T Cell Ignorance and Induction of Anti-Tumor Immunity by Peptide-Pulsed APC
title_full Reversal of CD8+ T Cell Ignorance and Induction of Anti-Tumor Immunity by Peptide-Pulsed APC
title_fullStr Reversal of CD8+ T Cell Ignorance and Induction of Anti-Tumor Immunity by Peptide-Pulsed APC
title_full_unstemmed Reversal of CD8+ T Cell Ignorance and Induction of Anti-Tumor Immunity by Peptide-Pulsed APC
title_short Reversal of CD8+ T Cell Ignorance and Induction of Anti-Tumor Immunity by Peptide-Pulsed APC
title_sort reversal of cd8+ t cell ignorance and induction of anti-tumor immunity by peptide-pulsed apc
topic Immunology
Immunology and Allergy
url http://dx.doi.org/10.4049/jimmunol.165.12.6731
publishDate 2000
physical 6731-6737
description <jats:title>Abstract</jats:title><jats:p>In the present report, we have studied the potential of naive and activated effector CD8+ T cells to function as anti-tumor T cells to a solid tumor using OVA-specific T cells from TCR-transgenic OT-I mice. Adoptive transfer of naive OT-I T cells into tumor-bearing syngeneic mice did not inhibit tumor cell growth. The adoptively transferred OT-I T cells did not proliferate in lymphoid tissue of tumor-bearing mice and were not anergized by the tumor. In contrast, adoptive transfer of preactivated OT-I CTL inhibited tumor growth in a dose-dependent manner, indicating that E.G7 was susceptible to immune effector cells. Importantly, naive OT-I T cells proliferated and elicited an anti-tumor response if they were adoptively transferred into normal or CD4-deficient mice that were then vaccinated with GM-CSF-induced bone marrow-derived OVA-pulsed APC. Collectively, these data indicate that even though naive tumor-specific T cells are present at a relatively high fraction they remain ignorant of the tumor and demonstrate that a CD8-mediated anti-tumor response can be induced by Ag-pulsed APC without CD4 T cell help.</jats:p>
container_issue 12
container_start_page 6731
container_title The Journal of Immunology
container_volume 165
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792342847011160073
geogr_code not assigned
last_indexed 2024-03-01T16:42:18.744Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Reversal+of+CD8%2B+T+Cell+Ignorance+and+Induction+of+Anti-Tumor+Immunity+by+Peptide-Pulsed+APC&rft.date=2000-12-15&genre=article&issn=1550-6606&volume=165&issue=12&spage=6731&epage=6737&pages=6731-6737&jtitle=The+Journal+of+Immunology&atitle=Reversal+of+CD8%2B+T+Cell+Ignorance+and+Induction+of+Anti-Tumor+Immunity+by+Peptide-Pulsed+APC&aulast=Malek&aufirst=Thomas+R.&rft_id=info%3Adoi%2F10.4049%2Fjimmunol.165.12.6731&rft.language%5B0%5D=eng
SOLR
_version_ 1792342847011160073
author Dalyot-Herman, Nava, Bathe, Oliver F., Malek, Thomas R.
author_facet Dalyot-Herman, Nava, Bathe, Oliver F., Malek, Thomas R., Dalyot-Herman, Nava, Bathe, Oliver F., Malek, Thomas R.
author_sort dalyot-herman, nava
container_issue 12
container_start_page 6731
container_title The Journal of Immunology
container_volume 165
description <jats:title>Abstract</jats:title><jats:p>In the present report, we have studied the potential of naive and activated effector CD8+ T cells to function as anti-tumor T cells to a solid tumor using OVA-specific T cells from TCR-transgenic OT-I mice. Adoptive transfer of naive OT-I T cells into tumor-bearing syngeneic mice did not inhibit tumor cell growth. The adoptively transferred OT-I T cells did not proliferate in lymphoid tissue of tumor-bearing mice and were not anergized by the tumor. In contrast, adoptive transfer of preactivated OT-I CTL inhibited tumor growth in a dose-dependent manner, indicating that E.G7 was susceptible to immune effector cells. Importantly, naive OT-I T cells proliferated and elicited an anti-tumor response if they were adoptively transferred into normal or CD4-deficient mice that were then vaccinated with GM-CSF-induced bone marrow-derived OVA-pulsed APC. Collectively, these data indicate that even though naive tumor-specific T cells are present at a relatively high fraction they remain ignorant of the tumor and demonstrate that a CD8-mediated anti-tumor response can be induced by Ag-pulsed APC without CD4 T cell help.</jats:p>
doi_str_mv 10.4049/jimmunol.165.12.6731
facet_avail Online, Free
finc_class_facet Medizin
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuNDA0OS9qaW1tdW5vbC4xNjUuMTIuNjczMQ
imprint The American Association of Immunologists, 2000
imprint_str_mv The American Association of Immunologists, 2000
institution DE-Zi4, DE-Gla1, DE-15, DE-Pl11, DE-Rs1, DE-14, DE-105, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161
issn 1550-6606, 0022-1767
issn_str_mv 1550-6606, 0022-1767
language English
last_indexed 2024-03-01T16:42:18.744Z
match_str dalyotherman2000reversalofcd8tcellignoranceandinductionofantitumorimmunitybypeptidepulsedapc
mega_collection The American Association of Immunologists (CrossRef)
physical 6731-6737
publishDate 2000
publishDateSort 2000
publisher The American Association of Immunologists
record_format ai
recordtype ai
series The Journal of Immunology
source_id 49
spelling Dalyot-Herman, Nava Bathe, Oliver F. Malek, Thomas R. 0022-1767 1550-6606 The American Association of Immunologists Immunology Immunology and Allergy http://dx.doi.org/10.4049/jimmunol.165.12.6731 <jats:title>Abstract</jats:title><jats:p>In the present report, we have studied the potential of naive and activated effector CD8+ T cells to function as anti-tumor T cells to a solid tumor using OVA-specific T cells from TCR-transgenic OT-I mice. Adoptive transfer of naive OT-I T cells into tumor-bearing syngeneic mice did not inhibit tumor cell growth. The adoptively transferred OT-I T cells did not proliferate in lymphoid tissue of tumor-bearing mice and were not anergized by the tumor. In contrast, adoptive transfer of preactivated OT-I CTL inhibited tumor growth in a dose-dependent manner, indicating that E.G7 was susceptible to immune effector cells. Importantly, naive OT-I T cells proliferated and elicited an anti-tumor response if they were adoptively transferred into normal or CD4-deficient mice that were then vaccinated with GM-CSF-induced bone marrow-derived OVA-pulsed APC. Collectively, these data indicate that even though naive tumor-specific T cells are present at a relatively high fraction they remain ignorant of the tumor and demonstrate that a CD8-mediated anti-tumor response can be induced by Ag-pulsed APC without CD4 T cell help.</jats:p> Reversal of CD8+ T Cell Ignorance and Induction of Anti-Tumor Immunity by Peptide-Pulsed APC The Journal of Immunology
spellingShingle Dalyot-Herman, Nava, Bathe, Oliver F., Malek, Thomas R., The Journal of Immunology, Reversal of CD8+ T Cell Ignorance and Induction of Anti-Tumor Immunity by Peptide-Pulsed APC, Immunology, Immunology and Allergy
title Reversal of CD8+ T Cell Ignorance and Induction of Anti-Tumor Immunity by Peptide-Pulsed APC
title_full Reversal of CD8+ T Cell Ignorance and Induction of Anti-Tumor Immunity by Peptide-Pulsed APC
title_fullStr Reversal of CD8+ T Cell Ignorance and Induction of Anti-Tumor Immunity by Peptide-Pulsed APC
title_full_unstemmed Reversal of CD8+ T Cell Ignorance and Induction of Anti-Tumor Immunity by Peptide-Pulsed APC
title_short Reversal of CD8+ T Cell Ignorance and Induction of Anti-Tumor Immunity by Peptide-Pulsed APC
title_sort reversal of cd8+ t cell ignorance and induction of anti-tumor immunity by peptide-pulsed apc
title_unstemmed Reversal of CD8+ T Cell Ignorance and Induction of Anti-Tumor Immunity by Peptide-Pulsed APC
topic Immunology, Immunology and Allergy
url http://dx.doi.org/10.4049/jimmunol.165.12.6731